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The role of Angiotensin in the cardiovascular and renal response
to salt restriction. Dietary sodium restriction in rabbits resulted in
a significant reduction in cardiac output: blood pressure was well
maintained through an increase in total peripheral resistance.
Renal blood flow, measured with tagged microspheres, and
glomerular filtration rate were reduced with salt restriction.
There was a larger reduction in outer cortical than inner cortical
flow rates. Blockade of the renin-angiotensin system with either
a competitive antagonist to angiotensin 11(1 -sar, 8-ala angiotensin
II) or inhibition of converting enzyme (SQ 20881) reduced
arterial pressure in animals on a low salt diet but not on a high
salt diet. Similarly, renal blood flow increased only in animals
on a low salt diet despite the fall in arterial pressure, suggesting
that the vasoconstriction was mediated by the renin-angiotensin
system. Despite the increase in total and outer cortical renal
blood flow, however, neither an increase in the glomerular
filtration rate nor natriuresis occurred in animals on a low salt
diet: either the renal vascular response did not contribute to the
functional effects of salt restriction or the hypotensive response
overrode the renal vascular effects on sodium handling and
filtration rate.
Role de I'angiotensine dans Ia réponse cardiovasculaire et
rénale a Ia restriction en sel. La restriction en sodium alimentaire
chez le lapin determine une diminution significative du debit
cardiaque: Ia pression artérielle est maintenue par l'intermédiaire
d'une augmentation des resistances périphériques. Le debit
sanguin renal, mesuré avec des microsphères marquees, Ct le
debit de filtration glomérulaire sont diminués au cours de Ia
restriction de sel. La reduction est plus importante pour le debit
cortical externe que pour l'interne. Le bloquage du système
rénine-angiotensine avec un antagoniste compatiteur de
l'angiotensine II (1-sar, 8-ala angiotensine II) ou par l'inhibition
de l'enzyme de conversion (SQ 20881) diminue Ia pression
artérielle chec les animaux soumis a un régime pauvre en sel mais
pas celle des animaux soumis a un régime riche en sd. De Ia
méme facon, le debit sanguin renal n'augmente que chez les
animaux soumis a un régime pauvre en sd, malgré Ia baisse de Ia
pression artérielle, cc qui suggére que le systeme rénine-angio-
tensine est le médiateur de Ia vasoconstriction. En dépit de
l'augmentation du debit sanguin renal total et cortical externe ni
une augmentation du debit de filtration glomérulaire ni une
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natriurèse ne sont observes chez les animaux soumis au régime
pauvre en sd: ou bien la réponse vasculaire rénale ne contribue
pas aux effets fonctionnels de Ia restriction sodique, ou bien Ia
réponse hypotensive outrepasse les effets vasculaires rénaux en
cc qui concerne Ic comportement du sodium et Ia filtration
glomerulaire.
Angiotensin is the most active endogenous vaso-
constrictor agent yet identified [1, 2]. Despite a
prodigious body of investigation, however, its precise
role in normal cardiovascular homeostasis has not
been clearly delineated. Several lines of evidence
suggest that angiotensin II is generated within the
kidney [3—5], and thus may participate in local adjust-
ments of perfusion within the renal cortex. The recent
development of pharmacologic agents which interfere
with the renin-angiotensin system, either through
inhibition of the enzyme which catalyzes the con-
version of angiotensin I to angiotensin II [5, 6 or
through competitive antagonism of angiotensin 11 at
the receptor level [7, 8], has provided a new approach
to assessing the cardiovascular actions of angiotensin
II.
Restriction of sodium intake provides a major
stimulus to activation of the renin-angiotensin
system, and induces a reduction of renal blood flow
through poorly understood mechanisms [9, 10].
Recently a competitive antagonist increased renal
perfusion dramatically in dogs in which a major
sodium deficit was induced by combining a low salt
diet with aggressive diuretic therapy or thoracic caval
occlusion [11]. Renal blood flow was not influenced in
the normal dog. In this study we have used blockers
to examine the role of angiotensin in the genesis of the
renal blood flow reduction and intracortical flow
redistribution induced by simple restriction of sodium
intake.
Salt restriction and angiotensin 349
Methods
The studies were performed in 36 New Zealand
white rabbits weighing 2.5 to 3.5 kg. At least seven days
prior to study, 13 rabbits were placed on a special,
sodium-deficient test diet (General Biochemicals
#170940) and tap water was replaced with distilled
water. A high sodium intake was achieved in seven of
the 13 on this diet by supplementing it with 7 to 10 g of
sodium/kg of chow. The effectiveness of the diets was
assessed through analysis of urine collected at the
time of study. Sodium excretion was less than 2 Eq/
mm in animals on a low salt regimen and exceeded
20 Eq/min with supplementation. The other 23 were
on an ad lib diet which provided a wide range of
sodium intakes, intermediate between the low and
high salt diet.
Anesthesia was induced with sodium thiopental
(about 30 mg/kg) administered into an ear vein hnd
sustained with chloralose (60 mg/kg) and urethane
(900 mg/kg). This regimen was supplemented with
lidocaine infiltrated subcutaneously prior to skin
incision. Tracheostomy was performed routinely, but
respiratory assistance (Harvard Instruments small
animal respirator) was rarely required. Body tem-
perature was monitored with a rectal probe (Yellow
Springs Instrument Co.) and maintained at 36 to 37°C
with an infrared heat lamp.
Arterial blood pressure was monitored from a
PE9O (Clay Adams) polyethylene catheter in the
right femoral artery with a transducer (Statham
P23dB). A tapered PE9O catheter was advanced from
the right carotid artery into the left ventricle, where its
presence was verified by a typical ventricular pressure
trace and fluoroscopy in some cases.
Duplicate cardiac output measurements were ob-
tained by injecting 0.15 ml of an indocyanine green dye
solution containing 1.25 mg/mI into the left ventricle.
Arterial blood was withdrawn from the femoral
artery through a densitometer (Gilford) at a rate of
10 ml/min. The dye curve evolved in less than 30 sec,
and the blood was reinfused. Concordance was
generally within l0% on the duplicate curves and the
mean was used. The densitometer was calibrated at the
end of each experiment with blood containing dye
concentrations bracketing those obtained during the
study. Cardiac output was calculated with correction
for recirculation according to standard methods. All
pressures and dilution curves were recorded on a
Visicorder (Honeywell) and polygraph (Grass Instru-
ments).
Renal blood flow was measured with radioactive
microspheres. About 60,000 beads with an average
diameter of 15 5 .t (3M Co.) were used for each
determination. The preparation of microspheres in
this laboratory has been described in detail [12]. In
brief, the microspheres were suspended in 2 ml of a
sucrose solution and infused into the left ventricle over
20 to 30 sec. The three isotopes used were 85Sr, '41Ce
and 51Cr: pulse-height analysis and appropriate cor-
rections for crossover allowed three determinations of
renal blood flow. Blood flow was calculated as the
product of cardiac output and the percent of micro-
spheres administered which came to rest in the region
of interest. The method assumes that microspheres,
when mixed well with blood flowing through the left
ventricle, are distributed to each vascular bed in
proportion to its fraction of cardiac output [12].
Right ureteral catheterization was achieved through
a small suprapubic incision. Serial 10- to 20-mm
collections of urine were analyzed for osmolality and
their content of sodium, potassium and creatinine.
Plasma samples were drawn at the beginning and end
of the experiment for similar analyses. No differences
were found in either cortical blood flow or mean blood
flow rates in the kidneys in which a ureter was cathe-
terized (y) and the contralateral untouched kidney (x)
(y=l.005x—0.Ol: rz=0.95;P<0.OOl).
The assumptions implicit in the measurement of
mean renal blood flow and its cortical distribution
were assessed in 14 rabbits. In eight the renal vein was
catheterized, allowing the direct measurement of
blood flow through timed collections. Blood flow was
also measured simultaneously with the microsphere
method. In another six, sections of the kidney were
dehydrated with ethanol and cleared with methyl-
salicylate [13]. In these kidneys the size of microspheres
in the outer cortex, midcortex and inner cortex were
measured with a micrometer eyepiece which could be
read to less than 0.1 (Don Santo Inc., Wellesley,
Massachusetts). At least 100 microspheres were
measured in each zone. Measurements were made in
two animals on a high salt diet and four with restricted
sodium intake.
An identical protocol was used for each experiment.
After the necessary surgery and catheterizations were
performed, a minimum interval of 30 mm was allowed
for recovery from the effects of surgery. During this
control period blood pressure and heart rate were
monitored continuously and serial urine collections
were made. When the animal was stable, cardiac out-
put and renal blood flow were determined. Following
these determinations one of several subprotocols was
followed. In four animals serial determinations were
made over approximately 90 mm without administra-
tion of a pharmacologic agent to assess the stability of
the preparation and reproducibility of the methods.
Spontaneous variations in every variable were random
in direction and did not exceed l0%, the probable
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Table 1. The effect of salt intake on renal function and perfusion
Salt intake Low inter-
mediate
High P (low vs.
high)
N 6 23 7
Blood pressure, mm Hg 76.3±4.4 78.1±2.5 81.3±4.9 NS
1-lematocrit, 36.5±0.7 36.9± 1.0 37.5± 1.1 NS
Mean renal flow, ml/g/min 3.5±0.2 4.2±0.3 5.6± 0.4 0.001
Outer cortical flow, mug/mm 5.7±0.3 7.2± 0.5 9.8±0.5 0.001
Inner cortical flow, mug/mm 2.3±0.2 2.8±0.2 3.6±0.5 0.05
Outer cortex/inner cortex 2.48±0.1 2.73±0.2 2.91 0.05
Outer cortex, % of kidney weight 47.4± 1.2 46.7± 1.2 46.1 1.1 NS
Inner cortex, % of kidney weight 29.7± 1.8 31.5± 1.0 28.6± 1.0 NS
GFR, ml/g/niin 0.35 0.41 0.49±0.043 0.005
UNV, p.Eq/min 1.0± 0.3 16.8±4.4 24.2± 6.0 0.005
CNJGFR 0.25 0.02 2.79 0.71 4.65 0.93 0.005
GFR=glomerular filtration rate; U0V=urinary excretion of sodium; CNO=clearance of sodium.
cortex, inner cortex and medulla and the individual
sections analyzed for radioactivity. Each entire kidney
was processed. Outer cortex was obtained by dividing
the cortical segment at its midpoint: this convention
resulted in approximately two-thirds of the cortical
mass being defined as "outer cortex."
intrinsic error in most of the measurements made. In
the others, infusions of graded doses of one of the
antagonists were then initiated. In four rabbits on a
low salt diet and six with sodium supplementation,
graded doses of 1-sar, 8-ala angiotensin II (P 113) in
log-dose increments from 0.03 to 10 g/kg/min were
administered over at least 30 mm. in four animals,
including two in low salt balance, pentapeptide
(Squibb, SQ 20475) or nonapeptide (Squibb, SQ 20881)
was infused at 500 g/kg over 10 mm. The effective-
ness of P 113 in antagonizing angiotensin Ii's effect on
renal blood flow and pressure [161 and Squibb pep-
tides in antagonizing angiotensin l's effect on blood
pressure was assessed in at least four animals each.
The doses of both class of blocking agent were similar
to those used by earlier investigators [5—7], and were
effective. P 113 (1 g/kg/min) reduced the increase in
renal vascular resistance by infusion of angiotensin 11
at 1 g/kg/min by 50%. SQ 20881 (0.5 fig/kg) reduced
the pressor response to angiotensin 1 (100 mg/kg) by
50%. Details on the characteristics of blockade in-
duced by these agents are available [16, 17].
Arterial pressure was monitored and urine samples
were collected throughout the infusion. The cardiac
output and renal blood flow were reassessed for each
protocol 30 mm after the infusion was initiated.
Following the infusion the animals were killed and a
postmortem examination made to rule out significant
disease. Kidneys were weighed, sectioned into outer
Salt intake High Low
Mean blood pressure,
mmHg
High Low
Cardiac output, mI/mm/kg
200
120
40
Cortical flow, ml/min/gMean renal blood flow
6 ml/min/g
II
Glomerular filtration
rate, ml/min/g
0.50
:: I
Fig. 1. Systemic and renal vascular response to sodium restric-
tion: only mean blood pressure was not reduced significantly by
that maneuver. Note that the scale for cortical perfusion rates is
twice that for mean renal blood flow. There are six animals in
the low salt group and seven on a high salt intake. IJNV=
urinary excretion of sodium.
UNflV, t4Eq/min
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Mean values have been expressed with the standard
error of the mean as the index of dispersion. Statistical
significance was assessed with Student's t test for
paired data where appropriate, or the Wilcoxon Rank
Sum Test for nonparametric data. The null hypothesis
was rejected when the P value was less than 0.05 [14].
Results
The systemic and renal effects of modifying salt
intake are summarized in Fig. I and Table 1. Arterial
pressure in animals on a high salt diet was 81.3
mm Hg, not significantly higher than pressure in the
sodium-restricted group (76.3 4.4 mmHg; F> 0.5).
There was, however, a striking difference in cardiac
output, which averaged 197 9.7 ml/kg/min in ani-
mals on a high salt diet and 150 7 mI/kg! mm in those
on restricted sodium intake (P<0.001). Thus, a
E
U
0
I
significant increase in total peripheral resistance pre-
vented a drop in blood pressure in animals with
restricted salt intake.
The renal vascular and functional effects of sodium
restriction are summarized in Fig. I and 2 and Table 1.
Mean renal blood flow in animals on a high salt intake
was 5.6 0.4 ml/g/min, significantly higher than mean
blood flow in animals on the sodium-restricted intake
(3.5 ml/g/min; P<0.001). Similarly, there was a
highly significant difference in glomerular filtration
rate, sodium excretion and sodium clearance. Serum
sodium concentration, potassium concentration and
urinary potassium excretion were not significantly
different in the two groups. The animals on an un-
restricted, generally intermediate salt intake showed
intermediate values for all renal vascular and func-
tional indices (Table 1).
Regional intrarenal perfusion rates, assessed with
the microsphere method, were also altered with
changes in sodium intake. Sodium restriction was
associated with both a decrease in outer cortical and
inner cortical flow rates. The differences in flow rate,
however, were not precisely parallel: the ratio of
outer to inner cortical flow was 2.9 0.2 in the animals
on a high salt diet and 2.48 0.1 with sodium restric-
tion (P<0.05). A more detailed analysis of the
relationships between mean renal blood flow and
intrarenal perfusion rates is shown in Fig. 2. The
slope relating outer cortical flow to mean renal blood
flow (l.6x) was significantly steeper than that relating
inner cortical to mean blood flow (0.73x; P<0.OOl).
Outer and inner cortical flow rates in animals on an
unmodified, intermediate salt intake also fell on the
same regression relationships. Thus, over a wide range
4
2
10
0
2
2 4 6 8 10 12 14
Direct measurement, mi/mm
lb iS
Fig. 3. Relationship between renal blood flow measured directly
and with the microsphere method.
r=0.98
P< 0.001
S
61 2 3 4 5 7
Mean renal blood flow, mug/mm
Fig. 2. The relationship between mean renal blood flow and intra-
renal perfusion rates; note that there is a continuum, with values
for animals on a restricted sodium intake at the lower end whereas
those for animals on a high salt intake lie at the upper end.
Animals on an unrestricted intake showed a wide range of
sodium excretion and a wide range of perfusion rates which fell
along the same regression relationships. The difference between
the slopes for outer and inner flow rates is highly significant.
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Fig. 4. Arterial pressure ( MBP) responses to an angiotensin
antagonist (P 113) and inhibitors of angiotensin I converting
enzyme. Note the uniform reduction in arterial pressure in
response to these agents in animals on a low salt intake and
random changes in animals on a high salt intake. O=P 113,
0.03 sg/kg/min; x =P 113, 0.30 g/kg/min; •=P 113, 1.00
sg/kg/min; L1=P 113, 10.0 sg/kg/min; A=SQ 20881, 500 g/
kg/mm; A=SQ 20475, 500 Lg/kg/min.
of renal blood flow the magnitude of changes in outer
cortical flow was over twice that of the changes in
inner cortical flow. The mass of outer to inner cortex
was identical in the three groups, so that a systematic
difference in sectioning the kidney did not occur
(Table 1). Radioactivity in the medulla rarely ex-
ceeded the level of radioactive residue as the micro-
spheres were largely confined to the cortex.
In the experiments in which microsphere size in
outer, mid and inner cortex was assessed by direct
measurement, no significant difference was detected.
The mean diameter of microspheres in the outer
cortex was 15.90±0.27 in the midcortex micro-
spheres averaged 15.98 0. l9i; and in the inner cortex
microspheres measured 15.5 0.50 . One would
anticipate a gradient of microsphere size from outer to
inner cortex if significant streaming occurred [25, 26].
No difference of microsphere size was identified in the
three cortical zones. In the eight rabbits in which
blood flow was measured directly as the venous
effluent simultaneously with microspheres, an ex-
cellent correlation (r==0.95; P<0.001) was found over
a range of flow from 4 to 18 mi/mm (Fig. 3).
The infusion of both classes of antagonist had
striking effects in animals on a low salt diet. The blood
pressure responses are summarized in Fig. 4 where a
uniform reduction in pressure of 10 to 19 mm Hg is
evident. The blood pressure began to fall within one
minute during the infusion of P 113 and in three
minutes with SQ 20881, reaching a stable minimum in
ten minutes with both agents in the low salt animals.
The reduction of blood pressure was due to arteriolar
dilatation, as total peripheral resistance fell signifi-
cantly (0.51 0.03 to 0.41 0.02 mm Hg/mi/mm;
P<0.Ol) whereas cardiac output was essentially un-
changed (150.0± 7.0 vs. 153.3±9.6 mi/kg/mm). Blood
pressure began to return to control levels within 5 mm
after cessation of the P 113 infusion and was no longer
significantly lower than control by 15 mm. Changes in
animals on a high salt diet were random, rarely ex-
ceeding 5 mm Hg. The difference in the response of the
two populations is highly significant (P.<0.00l).
+2 Low salt High salt
+1
0 —1
'000
0
—20 Low salt High salt
—3
+1
—1
—3
+10
>
Fig. 5. Reduced sodium intake associated with an increase in
renal blood flow despite the fall in perfusion pressure when
inhibitors were administered. Neither glomerular filtration rate
(GFR) nor renal sodium excretion ( UNV) was changed by
the inhibitors. Conversely, animals on a high salt diet showed a
striking reduction in renal blood flow despite an unchanged
arterial pressure, perhaps reflecting P 113's action as a partial
antagonist. Q=P 113, 0.03 g/kg/min; x =P 113, 0.30 g/kg/
mm; •=P 113, 1.00 g/kg/min; E=P 113, 10.0 g/kg/min;
A=SQ 20881, 500 g/kg/min; A=SQ 20475, 500 g/kg/min.
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Fig. 6. The effect of antagonists on outer and inner cortical per-
fusion rates. The 95% confidence intervals for flow in each zone
are derived from the data shown in Fig. 2.
Similarly (Fig. 5) opposite effects on renal blood
flow were evident. Both classes of agent induced a
significant increase in renal blood flow in animals on a
low salt diet despite the fall of arterial pressure, where-
as flow was either little changed or fell with both
classes of agent in animals on a high salt diet. The
blockers increased outer cortical flow more than inner
in the sodium-depleted rabbits (Fig. 6). Neither the
converting enzyme blockers nor the competitive
antagonist induced a consistent or significant change
in either glomerular filtration rate or the rate of
sodium excretion, despite the increase in renal blood
flow. A natriuresis did not occur despite even pro-
longed periods of infusion.
Discussion
Restriction of sodium intake induces a large number
of physiologic responses, including an increase in
circulating renin and angiotensin II concentrations
[15]. The thrust of this study was to document a
number of these responses and explore the role of
angiotensin in their genesis. Evidence based primarily
on a pharmacologic assessment with a blocker must be
suspect, as few agents enjoy a single action. The
rationale of this study, therefore, was to employ two
classes of agents with unrelated structure, a different
locus of action and probably different secondary or
side effects. P 113 is an analog of angiotensin II which
acts as a competitive antagonist at the level of the
angiotensin receptor: not surprising in a structural
analog this agent is a partial antagonist and may display
angiotensin-like activity in some systems [16]. An
expression of that action likely accounts for the reduc-
tion in renal blood flow induced by P 113 in the
animals on a high salt intake. The Squibb peptides act
as antagonists of the enzymatic conversion of angio-
tensin I to the active octapeptide angiotensin II and
potentiate the circulatory effects of bradykinin.
Increased experience will probably uncover additional
actions for each agent. Because of their differences in
structure and mechanism of action, it is reasonable to
ascribe an identical response to a single, shared
action—interference with the renin-angiotensin system.
Sodium restriction did not reduce blood pressure
significantly, but there was a marked reduction in
cardiac output: a consequent reduction in blood
pressure was prevented by active vasoconstriction and
an increase in total peripheral resistance. The reduction
in blood pressure and decrease in total peripheral
resistance induced by both classes of antagonist in
animals on a restricted salt intake makes it very likely
that angiotensin contributed to vasoconstriction and
maintenance of blood pressure in that setting. There
has been considerable interest in the role of angio-
tensin in normal blood pressure homeostasis [18].
Recent observations are in accord with such a role and
suggest that salt intake is the major determinant of
angiotensin's contribution to blood pressure homeo-
stasis [11, 19—24]. With increased sodium intake it is
unlikely that angiotensin is important in arterial
pressure homeostasis despite the increase in sensitivity
to angiotensin which characterizes that state [19—21].
The cardiac output increase with liberalization of
sodium intake probably was consequent to an increase
in plasma volume, which was not measured in this
study.
Restriction of sodium intake also modified the renal
vascular response to both classes of agent: an increase
in renal blood flow occurred despite a reduction in
arterial pressure. Angiotensin II must have contributed
to the reduction in renal blood flow induced by salt
restriction. Mean blood flow was reduced about 2 ml/
g/min with salt restriction, and rose about 1 n-il/g/min
with apparently adequate blockade. Whether the
residual reduction in blood flow was due to the
parallel reduction in blood pressure, incomplete
blockade of angiotensin or the action of additional
factors cannot be determined at this time. Because
blood pressure frequently fell below the usual auto-
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regulatory level, it seems likely that the fall contributed
to the antagonist's failure to return renal flow to that
level in the sodium-replete state.
While the assessment of intrarenal perfusion pat-
terns was not central to the goals of this study, the
measurements were made to explore the possibility
that endogenous angiotensin generation played a role
in the control of regional cortical perfusion. Implicit in
the use of tagged microspheres to make this measure-
ment is the assumption that streaming does not in-
fluence their distribution in the renal cortex. While
apparently rigorous evidence has made this unlikely
[25, 26], the assumption has been challenged [27].
Direct measurement of microsphere size in our study
made streaming an unlikely factor and made it
possible to use their distribution in the cortex as an
index of regional perfusion rates. Reciprocal changes
in outer and inner cortex perfusion with changes in
sodium balance—as might have been anticipated from
certain micropuncture data [28]—were not found.
Rather both outer and inner cortical flow rates were
reduced with sodium restriction. The reduction was
not parallel, however. Over a very wide range of flow
rates and sodium intakes, the slope of the regression
relationship between outer cortical and mean flow was
more than twice that in the inner cortex. The same
evidence that suggested that total renal blood flow
changes were mediated by angiotensin 11 is applicable
to the changes in regional cortical perfusion rates:
blockers raised outer cortical flow more than inner
(Fig. 6). The results are in accord with the elegant
morphologic observations of Hornych et al [29]. The
functional implications of these patterns have not been
clearly delineated despite considerable speculation.
Renal function, especially the rate of glomerular
filtration and sodium excretion, did not follow the
renal hemodynamic changes during the hyperemia
induced by blockers. There are two possible explana-
tions for this phenomenon. The first is that neither the
reduction in glomerular filtration rate nor that of
sodium excretion are mediated by endogenous angio-
tensin generation. The second is that angiotensin did
mediate these responses but the effect of blockade was
overridden by other factors in the response. A striking
reduction in arterial perfusion pressure occurred with
both classes of antagonist: the experimental design
did not make it possible to prevent the fall in pressure,
which ranged from 10 to 19 mm Hg, and, thus, re-
duced arterial pressure to a range of 56 to 70 mm Hg.
The reduction in arterial pressure may well have been
responsible, at least in part, for the failure of the
antagonists to reverse the effect of salt restriction on
glomerular filtration rate and sodium excretion. It is of
interest, in view of the recent demonstration that
P 113 will reduce aldosterone secretion [24], that even
a prolonged infusion did not result in a natriuresis.
One can conclude from these studies that angio-
tensin becomes an important mediator in normal
blood pressure homeostasis only with sodium restric-
tion. The renal vasculature shows an especially
striking participation in that process, which is most
marked in the outer cortex. The final role of angio-
tensin's influence on the renal vasculature in sodium
homeostasis cannot be defined until potentially
relevant factors are controlled.
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